ABT241018C117000
- 1.06
- -0.59-35.76%
Abbott Laboratories Newsroom
Abbott Laboratories Strategizing 'Price Wars' With CGM Flexibility, Oppenheimer Says
Abbott Laboratories' Q3 Results Show Strength of Diversified Business Model, RBC Says
Mizuho Securities Maintains Abbott Laboratories(ABT.US) With Hold Rating, Raises Target Price to $130
Abbott Labs Price Target Raised to $130.00/Share From $115.00 by Mizuho
Abbott Labs Is Maintained at Neutral by Mizuho
These Analysts Increase Their Forecasts On Abbott Laboratories After Better-Than-Expected Q3 Earnings
A Quick Look at Today's Ratings for Abbott Laboratories(ABT.US), With a Forecast Between $125 to $146
AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories
Meta To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Thursday
Abbott Laboratories Analyst Ratings
Goldman Sachs Remains a Buy on Abbott Laboratories (ABT)
Abbott Laboratories (ABT) Gets a Buy From Piper Sandler
Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Abbott Laboratories (ABT)
Morgan Stanley Adjusts Price Target on Abbott Laboratories to $117 From $107, Maintains Equalweight Rating
Express News | Abbott : Piper Sandler Raises Target Price to $133 From $131
Abbott Laboratories (ABT) Q3 2024 Earnings Call Highlights: Strong Growth in Diabetes Care and ...
Why Abbott Laboratories Stock Was a Winner on Wednesday
Cautious Outlook on Abbott Laboratories Amid Mixed Financials and Legal Challenges
Abbott Laboratories: Strong Growth Prospects and Strategic Positioning Drive Buy Rating
Earnings Call: Abbott Reports 8% Organic Sales Growth, Raises Guidance